| 000 | 01738 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250518042837.0 | ||
| 264 | 0 | _c20190624 | |
| 008 | 201906s 0 0 eng d | ||
| 022 | _a2041-1723 | ||
| 024 | 7 |
_a10.1038/s41467-019-10363-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBirkinshaw, Richard W | |
| 245 | 0 | 0 |
_aStructures of BCL-2 in complex with venetoclax reveal the molecular basis of resistance mutations. _h[electronic resource] |
| 260 |
_bNature communications _c06 2019 |
||
| 300 |
_a2385 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xmetabolism |
| 650 | 0 | 4 |
_aBridged Bicyclo Compounds, Heterocyclic _xmetabolism |
| 650 | 0 | 4 | _aCrystallization |
| 650 | 0 | 4 | _aCrystallography, X-Ray |
| 650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia, Lymphocytic, Chronic, B-Cell _xdrug therapy |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 | _aProtein Binding |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aSulfonamides _xmetabolism |
| 650 | 0 | 4 | _aSurface Plasmon Resonance |
| 700 | 1 | _aGong, Jia-Nan | |
| 700 | 1 | _aLuo, Cindy S | |
| 700 | 1 | _aLio, Daisy | |
| 700 | 1 | _aWhite, Christine A | |
| 700 | 1 | _aAnderson, Mary Ann | |
| 700 | 1 | _aBlombery, Piers | |
| 700 | 1 | _aLessene, Guillaume | |
| 700 | 1 | _aMajewski, Ian J | |
| 700 | 1 | _aThijssen, Rachel | |
| 700 | 1 | _aRoberts, Andrew W | |
| 700 | 1 | _aHuang, David C S | |
| 700 | 1 | _aColman, Peter M | |
| 700 | 1 | _aCzabotar, Peter E | |
| 773 | 0 |
_tNature communications _gvol. 10 _gno. 1 _gp. 2385 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/s41467-019-10363-1 _zAvailable from publisher's website |
| 999 |
_c29760753 _d29760753 |
||